We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Pharmaceutical Sciences and Drug Design

Volume 1 (2021)

Enhancing Meat Paste Production: Lithium-Based Technology Optimization
Written by Miftakhutdinova Elena   Published on Vol 1 , 2021
This paper aimed to create a method for turning fowl flesh that has been enhanced with lithium into a paste. The research achieved the best method for chopping minced meat for paste, which provides excellent organoleptic and physicochemical properties and low microbiological contamination. The process of rearing birds and supplementing their diet with fortified food raw materials (poultry meat) with a crucial element (lithium) has a bigger impact. The safety of using poultry paste enhanced with
Read More
Evaluating the Clinical Efficacy of Antiviral Treatments for SARS-CoV-2
Written by Angelique Welman   Published on Vol 1 , 2021
The virus that creates COVID-19, SARS-CoV-2, is highly contagious and typically replicates in the upper and lower respiratory tract to cause atypical pneumonia in humans. The gastrointestinal and cardiovascular tissues that contain its primary binding receptor, ACE2, may also be infected. A variety of therapeutic approaches have been investigated and modified to reduce the potentially dangerous clinical consequences of the COVID-19 pandemic. However, there isn't a proven cure for this illnes
Read More
Vitamin D Deficiency and Multiple Sclerosis: Investigating a Potential Association
Written by Mustafa Mohammed Al Brahim   Published on Vol 1 , 2021
Multiple sclerosis, an autoimmune demyelinating illness, is a common disease in young adults. Low vitamin D levels are a risk factor associated with multiple sclerosis. Numerous regulatory functions, particularly those related to the immune system, depend on vitamin D. Following the discovery of seasonal and geographic variations in the incidence of multiple sclerosis worldwide, it was suggested 50 years ago that vitamin D may play a role in the risk of developing and relapsing multiple sclerosi
Read More
Quality Evaluation of Sustained-Release Domperidone Formulations
Written by Zeb-un-Nisa Zeb-un-Nisa   Published on Vol 1 , 2021
Using hydrophilic Methocel® K4M, the current study sought to design a sustained-releasing and acting formulation of Domperidone, an antiemetic medication used to treat nausea and vomiting, with a typical dosage that is administered twice or three times per day. The sustained-release formulation was made using various ratios of K4M, and its quality and stability were assessed. The optimized formulation was chosen for dissolution studies and similarity profiles after pre-compression and post-compr
Read More
In Vitro Stability Assessment of Ketoprofen Tablets Under ICHQ1A Guideline
Written by Mariana Ganea   Published on Vol 1 , 2021
One of the critical components of the pharmaceutical industry is the capacity of pharmaceutical forms to remain stable over time and maintain their quality under different storage and transportation circumstances. Therefore, the amount of active components in the pharmaceutical form is evaluated following the ICHQ1A standards of the European Pharmacopoeia to ascertain the validity of the pharmaceutical product. This paper aims to investigate the stability of 100 mg ketoprofen tablets. Short-term
Read More
Formulation and Evaluation of Immediate-Release Quetiapine Fumarate Tablets
Written by Prashant Lakshaman Pingale   Published on Vol 1 , 2021
Antipsychotic medications can help manage the symptoms of schizophrenia. Several demographic and scientific elements have the potential to influence the choice of unusual neuroleptic drugs. Bipolar disorder and schizophrenia can be treated with quetiapine fumarate. When making tablets and hard-shell capsules, disintegrating agents are often utilized ingredients. The primary goal of this study was to develop a dependable immediate-release tablet formulation of the antipsychotic quetiapine. Tablet
Read More
Guben Kechuan Granules for Chronic Bronchitis: A Multicenter, Randomized, Controlled Trial Evaluating Efficacy and Safety
Written by Savannah Hayes   Published on Vol 1 , 2021
Chronic bronchitis (CB) is a long-standing inflammatory airway disorder with a high global burden and limited treatment success. In recent years, the combined use of traditional Chinese medicine (TCM) with standard medical care has been increasingly adopted for CB and has shown encouraging therapeutic potential. A multicenter randomized controlled trial directed by the China–Japan Friendship Hospital (Beijing, China) recruited 300 individuals with CB aged 18–75 years. Participants were allocated
Read More
A Novel Chronic Inflammatory Signature Guides Personalized Adjuvant Chemotherapy Selection in Early-Stage Colorectal Cancer: Superior Outcomes with De-escalated Regimens
Written by Oliver Brown   Published on Vol 1 , 2021
Tailored administration of adjuvant chemotherapy (ACT) enhances treatment efficiency and postoperative well-being in individuals with stage II–III colorectal cancer (CRC). Nonetheless, reliable biomarkers capable of forecasting responses to 5-fluorouracil (5-FU) and oxaliplatin remain insufficient. Three separate cohorts comprising 1676 stage II–III surgical cases were assessed to determine the prognostic value of 12 inflammatory markers. Using multivariable Cox modeling, we generated a novel Ch
Read More
Arterial Infusion Chemotherapy Embolization for Recurrent or Metastatic Soft Tissue Sarcoma: A Retrospective Study of 113 Patients
Written by Aiden Howard   Published on Vol 1 , 2021
This investigation assessed the practicality and tolerability of arterial infusion chemotherapy embolization (AICE) for patients with recurrent or metastatic soft tissue sarcoma (STS), and examined prognostic indicators that could support more personalized treatment planning. This retrospective analysis enrolled 113 individuals with recurrent/metastatic STS who underwent AICE at the Fifth Medical Center of the PLA General Hospital. Key endpoints included progression-free survival (PFS) and overa
Read More
Cadonilimab Combined with Chemotherapy Improves Survival as Second-Line Treatment in Immunotherapy-Pretreated Advanced HER2-Negative Gastric or Gastroesophageal Junction Cancer: A Real-World Study
Written by Miguel Santos   Published on Vol 1 , 2021
Immunotherapy has become a foundational component of first-line management for advanced gastric and gastroesophageal junction cancer (G/GEJC). After disease progression on such regimens, however, the optimal second-line approach remains uncertain. Because cadonilimab has demonstrated strong activity in initial treatment, this real-world analysis explored its use with chemotherapy in the second-line setting. We performed a retrospective review at a single institution involving patients with advan
Read More
Pharmacodynamic Modeling of Blood Pressure Reduction During Remimazolam Induction in Elderly Patients: A Modified Logistic Model with Body Weight as a Covariate
Written by Sofia Evans   Published on Vol 1 , 2021
Remimazolam is a newer hypnotic that generally preserves cardiovascular stability better than propofol during general anesthesia, a benefit that appears pronounced in older adults. Despite this, the extent to which remimazolam lowers blood pressure in a dose-related manner has not been formally quantified in this age group. We re-examined information from 432 individuals aged ≥ 65 years enrolled in a randomized trial comparing remimazolam with propofol for elective gastrectomy. Remimazolam was i
Read More
Neddylylation Inhibitor MLN4924 Reactivates TRIM58 through LINC01128-Dependent DNMT1 Sequestration in Acute Myeloid Leukemia
Written by Hannah Scott   Published on Vol 1 , 2021
This work aimed to clarify how MLN4924 influences acute myeloid leukemia (AML) biology, focusing on its ability to regulate TRIM58 promoter methylation and the downstream molecular events. RT-qPCR and Western blotting were applied to quantify transcript and protein levels, while methylation-sensitive restriction enzyme–qPCR assessed DNA methylation status. RNA sequencing was used to screen for lncRNAs with altered expression. Subcellular fractionation followed by PCR identified transcript locali
Read More
Altered Pharmacokinetics of Fospropofol Disodium in Moderate-to-Severe Hepatic Impairment: A Prospective Controlled Study
Written by Barbara Zielinska   Published on Vol 1 , 2021
Fospropofol disodium for injection (FospropofolFP) is a recently introduced, water-soluble precursor of propofol used for procedural sedation and induction of anesthesia. This prospective cohort investigation assessed how hepatic dysfunction affects the pharmacokinetics and safety of FospropofolFP during general anesthesia, comparing impaired subjects with matched healthy individuals. A total of 23 participants were recruited and grouped by liver status: normal hepatic function (n = 10), moderat
Read More
Novel 1,2,3-Triazole-Urea Conjugates as Potent and Liver-Selective Antiproliferative Agents: Synthesis, Biological Evaluation, and Mechanistic Insights
Written by Samuel Mensah   Published on Vol 1 , 2021
The need for effective targeted agents against hepatocellular carcinoma remains pressing. This investigation focused on designing and examining a new panel of triazole–urea hybrid molecules for potential anticancer activity. A collection of urea derivatives containing terminal alkynes was generated using a combined assembly and modification route. These intermediates were subsequently transformed through Click chemistry to afford novel triazole–urea hybrids (3a–3e, 5a–5e, 7a–7e). Their growth-in
Read More

About GalaxyPub

Find out more

Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.

Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.